Corebridge Financial’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-87,955	Closed	-$39.7K	–	1500
2025 Q1	$39.7K	Buy	87,955 +14,506	+20%	+$6.55K	﹤0.01%	2790
2024 Q4	$36.9K	Sell	73,449 -5,544	-7%	-$2.79K	﹤0.01%	2890
2024 Q3	$71.5K	Sell	78,993 -487	-0.6%	-$441	﹤0.01%	2757
2024 Q2	$79.3K	Buy	+79,480	New	+$79.3K	﹤0.01%	2721